Cooper Companies, Inc. (COO) on Thursday posted a net loss due to a substantial litigation-related charge tied to a 2023 product recall. However, the company reported higher revenues for the quarter.
The medical device maker reported a net loss of $77.9 million, or $0.40 per share, compared with net income of $87.7 million, or $0.44 per share, in the prior-year quarter.
Results were impacted by a $271.6 million pre-tax litigation-related charge related to resolving substantially all claims arising from CooperSurgical's December 2023 voluntary embryo culture media recall.
Excluding special items, adjusted income rose to $237.4 million, or $1.21 per share, from $193.5 million, or $0.96 per share, a year ago.
For the quarter, revenue increased 8% to $1.082 billion from $1.002 billion a year earlier. Organic revenue growth was 5%, while constant-currency revenue also rose 5%.
Looking ahead, CooperCompanies updated its fiscal 2026 outlook and now expects total revenue of $4.285 billion to $4.321 billion and adjusted earnings per share of $4.58 to $4.66.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.